The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ (null) Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab

類似資料

• Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγ(null) mice reconstituted with human peripheral blood mononuclear cells
  著者:: Jodeleit, Henrika, 等
  出版事項: (2021)
• Targeting ulcerative colitis by suppressing glucose uptake with ritonavir
  著者:: Jodeleit, Henrika, 等
  出版事項: (2018)
• A mouse model for ulcerative colitis based on NOD-scid IL2R γ(null) mice reconstituted with peripheral blood mononuclear cells from affected individuals
  著者:: Palamides, Pia, 等
  出版事項: (2016)
• NOD/scid IL‐2Rγnull mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype
  著者:: Anna‐Lena Unterweger, 等
  出版事項: (2021-12-01)
• CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis
  著者:: Al-amodi, Omar, 等
  出版事項: (2018)